about
Management of sexual dysfunction due to central nervous system disorders: a systematic reviewCurrent indications and results of orthotopic ileal neobladder for bladder cancer.Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.Proximal hypospadias repair with bladder mucosal graft: Our 10 years experience.Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy.Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients.The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml.The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.External Validation of the Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node DissectionPrognostic Role of Histological Necrosis for Nonmetastatic Clear Cell Renal Cell Carcinoma: Correlation With Pathological Features and Molecular MarkersFully automated solid-phase microextraction–fast gas chromatography–mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sedimentsPrognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer
P50
Q26863071-A07E335F-CBBE-44AA-B51E-59B24CCFC495Q38183895-3F560BE7-F529-4BDD-93C1-1C4B0F0EAA0AQ39144790-CCC5B628-1501-456F-92C4-56F09FDAEE24Q39304697-1FA0501A-980D-4F61-8A3F-69D32F703309Q40279117-7E4591DB-9B22-4761-A408-65FF3EB11D01Q40590766-F9D734B3-4C67-40BE-A37D-66EA9A022631Q42391707-E4827BEB-494F-4795-994C-E3E52BBB4C27Q42676692-B8359701-A182-4440-9BA0-8D85B572FCBFQ44632094-E9A7BD32-57E7-44F3-988F-91D4AA449A33Q45353776-038F2D4B-F473-4B23-9ACF-EE0E132D26DAQ46511261-1DFD709C-0C2F-4C48-868A-2752FD5AF3CBQ57582217-7160A0A5-5828-4250-8C14-B033B40ACA5CQ57582431-B3BA199E-DE57-4D89-9F0C-DD6AE650A029Q60706388-9913F246-1D47-4C2B-8360-79E2E3854955Q84339296-F3FAF395-E672-498F-95D4-C3FF089091C3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Lanciotti
@ast
Michele Lanciotti
@en
Michele Lanciotti
@es
Michele Lanciotti
@nl
Michele Lanciotti
@sl
type
label
Michele Lanciotti
@ast
Michele Lanciotti
@en
Michele Lanciotti
@es
Michele Lanciotti
@nl
Michele Lanciotti
@sl
prefLabel
Michele Lanciotti
@ast
Michele Lanciotti
@en
Michele Lanciotti
@es
Michele Lanciotti
@nl
Michele Lanciotti
@sl
P106
P1153
24528811100
P31
P3835
michele-lanciotti
P496
0000-0002-3368-8652